Core Viewpoint - Anhui Wanyi Technology Co., Ltd. has announced the use of idle self-owned funds for entrusted wealth management to improve capital efficiency and increase returns for shareholders [9][11]. Group 1: Financial Data and Reporting - The third-quarter financial statements have not been audited [3]. - The company guarantees the authenticity, accuracy, and completeness of the quarterly report [2]. - The company reported a total of 13,232.11 million yuan in surplus raised funds, which will be permanently supplemented into working capital [24][25]. Group 2: Investment Overview - The company plans to use up to 300 million yuan of idle self-owned funds for entrusted wealth management, ensuring it does not affect the normal operation of its main business [12][15]. - The investment will focus on high-security, high-liquidity financial products, including structured deposits and trust products [15][18]. - The investment period for the entrusted wealth management is valid for 12 months from the date of board approval [16]. Group 3: Project Completion and Fund Allocation - The company has completed the fundraising projects "Analysis and Testing Instrument Construction Project" and "Technical R&D Center Project," allowing for the conclusion of these projects [24][30]. - The surplus funds will be used to enhance the company's liquidity and operational efficiency [22][29]. - The decision to conclude the projects and allocate surplus funds was approved in the board meeting held on October 23, 2025, without requiring shareholder approval [30][31].

Core Insights - Anhui Wanyi Technology Co., Ltd. (Wanyi Technology) has reported strong financial performance for the third quarter of 2025, with a revenue of 211 million yuan, representing a year-on-year growth of 32.59% and a net profit of 24.72 million yuan, a significant increase of 1033.18% [1][2] Financial Performance - For the first three quarters of the year, Wanyi Technology achieved a total revenue of 519 million yuan, marking a year-on-year increase of 13.84% [1] - The net profit attributable to shareholders for the same period was 25.76 million yuan, indicating a turnaround from previous losses [1] Technological Advancements - The company's impressive performance is attributed to breakthroughs in core technologies and a strong response to market demand [1] - Wanyi Technology has focused on independent innovation in key areas such as chromatography, spectroscopy, and mass spectrometry, successfully achieving critical technological advancements [1] Product Development - The LCMS-TQ9200 liquid chromatography tandem mass spectrometry system has gained significant market attention, integrating self-developed technologies that enhance stability and sensitivity in complex sample detection [1] - This system is widely applied in various fields, including food safety, biomedicine, and environmental protection, serving as a key driver for revenue growth [1] Government Support - In the third quarter, Wanyi Technology received government subsidies amounting to 7.96 million yuan, further enhancing its profit margins [2] Market Positioning - Experts suggest that Wanyi Technology's strong performance is a result of concentrated technological accumulation and strategic market positioning, with expectations of a more significant role in the domestic precision scientific instrument market [2] - The company is focused on technological innovation and expanding its market presence in precision scientific instruments, responding to industry demands for precise detection and intelligent analysis [2] Investment Projects - As of October 19, the company's initial public offering (IPO) fundraising projects, including the "Analytical Instrument Construction Project" and "Technology Research and Development Center Project," have reached a state of readiness for use [2] - The fixed assets formed from these projects are expected to optimize the company's asset structure and enhance its risk resistance capabilities [2]

Core Insights - Anhui Wanyi Technology Co., Ltd. (Wanyi Technology) reported a significant financial turnaround in Q3 2025, achieving a net profit of 25.76 million yuan, compared to a loss in the previous year [1][2] - The company's revenue for the first three quarters reached 519 million yuan, marking a year-on-year growth of 13.84% [1] - In Q3 alone, Wanyi Technology's revenue was 211 million yuan, reflecting a substantial increase of 32.59% year-on-year, with net profit soaring by 1033.18% [1] Financial Performance - For the first three quarters of 2025, Wanyi Technology's revenue was 519 million yuan, up 13.84% from the previous year [1] - The net profit attributable to shareholders was 25.76 million yuan, indicating a successful turnaround from previous losses [1] - In Q3, the company achieved revenue of 211 million yuan, a 32.59% increase year-on-year, and a net profit of 24.72 million yuan, up 1033.18% [1] Technological Advancements - Wanyi Technology's impressive performance is attributed to breakthroughs in core technologies and a strong market demand response [1][2] - The company has focused on independent innovation in key areas such as chromatography, spectroscopy, and mass spectrometry [1] - The LCMS-TQ9200 liquid chromatography tandem mass spectrometry system has gained significant market attention, showcasing excellent stability and sensitivity in complex sample detection [1] Market Position and Strategy - Wanyi Technology is positioned to play a crucial role in the domestic precision scientific instrument market, driven by continuous technological breakthroughs and expanding application scenarios [2] - The company emphasizes technological innovation and focuses on its core business in precision scientific instruments, enhancing its market advantage [2] - The completion of fundraising projects, including the "Analytical Instrument Construction Project" and "Technology R&D Center Project," is expected to optimize the company's asset structure and improve risk resistance [2]

Investment Rating - The investment rating for the company is "Accumulate" [4]. Core Views - The company reported a revenue of 519 million yuan for the first three quarters of 2025, representing a year-on-year increase of 13.84%. The net profit attributable to the parent company was 26 million yuan, marking a turnaround from losses [1]. - In Q3 2025, the company achieved a revenue of 211 million yuan, a year-on-year increase of 32.59% and a quarter-on-quarter increase of 21.46%. The net profit attributable to the parent company was 25 million yuan, showing a significant year-on-year increase of 1033.18% and a quarter-on-quarter increase of 280.36% [2]. - The gross margin for the first three quarters of 2025 was 49.10%, an increase of 1.65 percentage points year-on-year. The gross margin for Q3 2025 was 47.98%, a slight decrease of 0.14 percentage points year-on-year [3]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company reported a revenue of 519 million yuan, with a year-on-year growth of 13.84%. The net profit attributable to the parent company was 26 million yuan, indicating a recovery from previous losses [1]. - In Q3 2025, the company achieved a revenue of 211 million yuan, reflecting a year-on-year increase of 32.59% and a quarter-on-quarter increase of 21.46%. The net profit attributable to the parent company reached 25 million yuan, a year-on-year increase of 1033.18% [2]. Business Segments - The industrial testing instruments and solutions segment continues to focus on product leadership in the new energy sector while exploring growth opportunities in semiconductors and overseas markets. A joint laboratory agreement was signed with the Hefei Comprehensive National Science Center for the development of key vacuum measurement equipment [4]. - The online monitoring instruments and solutions segment is gradually transitioning to digitalization, focusing on pollution source and environmental monitoring, with new opportunities in air stations and industrial processes [4]. - The laboratory analysis instruments and solutions segment is concentrating on drinking water testing and has made significant progress in earthquake system layouts. The company is also actively participating in equipment updates for universities [4]. - The medical instruments and solutions segment has made breakthroughs in minimally invasive surgical instruments and high-value consumables, with successful registrations for ultrasound surgical devices [7]. Market Expansion - The company has successfully expanded its products to over 20 countries and regions globally, establishing a presence in Thailand and developing a network of overseas distributors. The overseas business revenue for H1 2025 was 8.72 million yuan, a year-on-year increase of 59.13% [8]. Earnings Forecast - The company maintains its earnings forecast for 2025-2027, expecting revenues of 854 million yuan, 1.02 billion yuan, and 1.21 billion yuan, representing year-on-year growth rates of 15.4%, 19.4%, and 19.0% respectively. The net profit attributable to the parent company is projected to be 59 million yuan, 79 million yuan, and 106 million yuan for the same period, with significant growth rates [9].

Core Insights - The company reported a revenue of 519 million yuan for the first three quarters of 2025, representing a year-on-year growth of 13.84% [1] - The net profit attributable to shareholders was 25.76 million yuan, marking a turnaround from a loss to profit compared to the previous year [1] - The non-recurring net profit was 10.31 million yuan, also indicating a recovery from a loss year-on-year [1] - The basic earnings per share stood at 0.20 yuan [1]

Core Insights - Anhui Yi Technology reported a third-quarter revenue of 211 million yuan, representing a year-on-year increase of 32.59% [1] - The net profit for the third quarter reached 24.72 million yuan, showing a significant year-on-year growth of 1033.18% [1] - For the first three quarters, the total revenue was 519 million yuan, which is a year-on-year increase of 13.84% [1] - The net profit for the first three quarters amounted to 25.76 million yuan [1]

证券代码：688600 证券简称：皖仪科技 公告编号：2025-062 安徽皖仪科技股份有限公司关于募投项目结项并将 节余募集资金永久补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 安徽皖仪科技股份有限公司（以下简称"公司"）于 2025 年 10 月 23 日召 开了第六届董事会第四次会议，审议通过了《关于募投项目结项并将节余募集资 金永久补充流动资金的议案》，同意公司募集资金投资项目（以下简称"募投项 目"）"分析检测仪器建设项目"、"技术研发中心项目"结项，并将预计节余募 集资金 13,232.11 万元（含利息收入和理财收益，实际金额以资金转出当日计算 的募投项目节余募集金额为准）永久补充流动资金。保荐机构国新证券股份有限 公司（以下简称"保荐机构"）对上述事项出具了明确同意的核查意见，本议案 无需提交股东会审议。 一、募集资金基本情况 单位：万元 | 项目名称 | 拟使用募集资金 | 累计投入金额 | 利息收入和理财产品 | 预计节余募集资 | | --- | --- | --- | --- ...

国新证券股份有限公司 经中国证券监督管理委员会《关于同意安徽皖仪科技股份有限公司首次公开发行股 票注册的批复》(证监许可【2020】999 号)核准,公司向社会公众公开发行人民币普 通股(A 股)3,334万股,每股面值 1.00元,每股发行价格为 15.50元。本次公开发行 募集资金总额为 51,677.00 万元,扣除总发行费用 5,846.76 万元(不含增值税),募集 资金净额为 45.830.24 万元。上述募集资金到位情况已经容诚会计师事务所(特殊普通 合伙)审验,并于 2020年 6 月 30 日出具了"容诚验字[2020]230Z0109 号"《验资报告》。 公司对募集资金采取了专户存储制度,设立了相关募集资金专项账户。募集资金到 账后,已全部存放于该募集资金专项账户内,并与保荐机构、存放募集资金的银行签署 了募集资金三方监管协议。具体情况详见 2020年7月2日披露于上海证券交易所网站 (www.sse.com.cn) 首次公开发行股票科创板上市公告书。 二、募集资金投资项目情况 根据公司披露的《安徽皖仪科技股份有限公司首次公开发行股票并在科创板上市招 股说明书》及公司 2021 年第二次临 ...

证券代码：688600 证券简称：皖仪科技 公告编号：2025-061 安徽皖仪科技股份有限公司 关于使用闲置自有资金进行委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 基本情况 | 投资金额 | 不超过人民币_30,000 万元(含本数) | | --- | --- | | 投资种类 | 安全性高、流动性好的银行及券商理财产品（包括但 不限于结构性存款、通知存款、定期存款、大额存单、 | | | 收益凭证等） | | 资金来源 | 自有资金 | 已履行的审议程序 安徽皖仪科技股份有限公司（以下简称"公司"）于 2025 年 10 月 23 日召开 了第六届董事会第四次会议，审议通过了《关于使用闲置自有资金进行委托理财 的议案》。本事项无需提交公司股东会审议。 特别风险提示 公司将选择安全性高、流动性好、低风险的理财产品进行委托理财，但金融 市场受宏观经济政策的影响较大，不排除该项投资会受到市场波动的影响。 一、投资情况概述 （一）投资目的 为提高公司资金使用效率，增加公司收益和股东回报，在确保 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥210,879,742.25, representing a year-on-year increase of 32.59%[3] - The total profit for the quarter was ¥24,772,733.00, showing a significant increase of 986.46% compared to the same period last year[3] - The net profit attributable to shareholders was ¥24,715,658.64, reflecting a year-on-year growth of 1,033.18%[3] - The net cash flow from operating activities for the year-to-date period was ¥73,943,348.52, an increase of 278.11% compared to the previous year[3] - Basic earnings per share for the first three quarters of 2025 were ¥0.20, recovering from a loss of ¥0.20 per share in the same period of 2024[21] - Net profit for the first three quarters of 2025 was ¥25,762,709.50, compared to a net loss of ¥26,683,108.65 in 2024, indicating a turnaround in profitability[20] Research and Development - Research and development expenses totaled ¥31,837,344.94 for the quarter, a decrease of 13.95% year-on-year, accounting for 15.10% of operating revenue[4] - Research and development expenses for the first three quarters of 2025 totaled ¥101,390,992.41, down from ¥117,609,418.14 in 2024, a decrease of 13.8%[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,298,353,756.44, an increase of 8.03% from the end of the previous year[4] - Total assets increased to ¥1,298,353,756.44 in 2025 from ¥1,201,819,195.09 in 2024, marking a growth of 8.0%[17] - Total liabilities rose to ¥538,388,236.52 in 2025, compared to ¥409,521,767.28 in 2024, an increase of 31.4%[17] - Non-current assets totaled ¥411,105,416.06 in 2025, up from ¥296,177,137.00 in 2024, reflecting a growth of 38.7%[17] Shareholder Information - Total number of common shareholders at the end of the reporting period was 4,295[11] - The largest shareholder, Zang Mu, holds 52,096,834 shares, representing 38.67% of total shares[11] Cash Flow and Investments - The company reported a significant increase in cash flow from operating activities, contributing to improved liquidity and financial stability[21] - Cash inflow from operating activities for the first three quarters of 2025 was $539.51 million, an increase of 10% compared to $490.38 million in the same period of 2024[22] - Net cash flow from operating activities for the first three quarters of 2025 was $73.94 million, significantly up from $19.56 million in the same period of 2024[22] - Cash inflow from investment activities decreased to $364.02 million in the first three quarters of 2025, down from $506.05 million in 2024, resulting in a net cash outflow of $44.49 million[23] - Cash received from the recovery of investments was $360.10 million in 2025, compared to $498.00 million in 2024, indicating a decline in investment recovery[22][23] - Total cash outflow for investment activities was $408.51 million in 2025, compared to $423.55 million in 2024, showing a slight decrease[23] Government Support - Government subsidies recognized during the period amounted to ¥7,964,420.98, contributing to the overall profit increase[6] Operational Efficiency - The company reported a significant increase in gross profit margin compared to the same period last year, driven by increased market demand for non-standard products[8] - Cash received from other operating activities increased to $36.93 million in 2025 from $20.64 million in 2024, reflecting improved operational efficiency[22] Accounting Standards - The company will not apply new accounting standards starting from 2025, maintaining consistency in financial reporting[24] Miscellaneous - The company has not disclosed any significant changes in shareholder relationships or actions[13] - There are no applicable reminders for investors regarding the company's operational situation during the reporting period[14] - The company has not provided any audited financial statements for the quarter[14]